beth
JF-Expert Member
- Aug 19, 2012
- 3,877
- 6,326
Kwa mujibu wa Utafiti uliochapishwa katika Jarida la "The New England Journal of Medicine", Wagonjwa 12 waliotumia Dawa ya Majaribio ya Dostarlimab kwa kipindi cha miezi 6 walionekana kupata nafuu. Jaribio hilo dogo limefanyika Nchini Marekani
Kwa mujibu wa Dkt. Luis Diaz, hii ni mara ya kwanza kutokea katika Historia ya Saratani. Japokuwa jaribio hilo limeonesha matokeo chanya, Wanasayansi wametahadharisha kuhusu kuhitimisha moja kwa moja kuwa Wagonjwa hao wamepona
Kwa takwimu za Shirika la Afya Duniani (WHO) Mwaka 2021, takriban watu Milioni 20 walibainika kuwa na Saratani, na wapatao Milioni 10 walipoteza maisha
TAARIFA ZAIDI....
An experimental cancer drug appears to have cured every single patient in a small clinical trial conducted in the US.
The 12 patients, all of whom had been diagnosed with rectal cancer, entered remission after taking dostarlimab over a six-month period, according to a study published in The New England Journal of Medicine.
“This is the first time this has happened in the history of cancer,” Dr Luis Diaz, one of the lead authors of the paper and an oncologist at the Memorial Sloan Kettering Cancer Centre in New York, told The New York Times.
The patients also experienced no significant side effects during the course of their treatment, though it’s believed not enough people were involved in the study to highlight the different adverse reactions that can be caused by the drug.
Although excited by the research, scientists have said the promising results will need to be repeated, and cautioned against concluding that the cancer had been eradicated permanently.
Dostarlimab is an immunotherapy drug used in the treatment of endometrial cancer, but this was the first clinical investigation into whether it could be effective against rectal cancer tumours.
The drug works by unmasking cancer cells, allowing the immune system to identify and destroy them.
For the research, the 12 patients received dostarlimab every three weeks for six months. This treatment was to be followed by standard chemoradiotherapy and surgery.
However, six months after the patients stopped taking the medication, their cancer had vanished, being undetectable by physical exam, endoscopy, PET or MRI scans.
Source: All cancer patients in drug trial appear to be cured for ‘first time in history’
Kwa mujibu wa Dkt. Luis Diaz, hii ni mara ya kwanza kutokea katika Historia ya Saratani. Japokuwa jaribio hilo limeonesha matokeo chanya, Wanasayansi wametahadharisha kuhusu kuhitimisha moja kwa moja kuwa Wagonjwa hao wamepona
Kwa takwimu za Shirika la Afya Duniani (WHO) Mwaka 2021, takriban watu Milioni 20 walibainika kuwa na Saratani, na wapatao Milioni 10 walipoteza maisha
TAARIFA ZAIDI....
An experimental cancer drug appears to have cured every single patient in a small clinical trial conducted in the US.
The 12 patients, all of whom had been diagnosed with rectal cancer, entered remission after taking dostarlimab over a six-month period, according to a study published in The New England Journal of Medicine.
“This is the first time this has happened in the history of cancer,” Dr Luis Diaz, one of the lead authors of the paper and an oncologist at the Memorial Sloan Kettering Cancer Centre in New York, told The New York Times.
The patients also experienced no significant side effects during the course of their treatment, though it’s believed not enough people were involved in the study to highlight the different adverse reactions that can be caused by the drug.
Although excited by the research, scientists have said the promising results will need to be repeated, and cautioned against concluding that the cancer had been eradicated permanently.
Dostarlimab is an immunotherapy drug used in the treatment of endometrial cancer, but this was the first clinical investigation into whether it could be effective against rectal cancer tumours.
The drug works by unmasking cancer cells, allowing the immune system to identify and destroy them.
For the research, the 12 patients received dostarlimab every three weeks for six months. This treatment was to be followed by standard chemoradiotherapy and surgery.
However, six months after the patients stopped taking the medication, their cancer had vanished, being undetectable by physical exam, endoscopy, PET or MRI scans.
Source: All cancer patients in drug trial appear to be cured for ‘first time in history’
